Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 mug/50 mug versus mometasone furoate inhalation powder

Authors
Category Primary study
Year 2013
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Epistemonikos ID: 7a1b9b252d5242151a0f2aa126eaecb7ead73476
First added on: Apr 19, 2023